- Home
- Pathology Industry
- Schizophrenia Market and Forecasts, May 2013
Industries
- Pathology (140)
- Drug and Medication (52)
- Managed Care (20)
- Pharmaceutical (10)
- Biotechnology (9)
-
- Drug Discovery and Development (9)
- Medical Facility (9)
- Healthcare (8)
- Tobacco (6)
- Biological Therapy (5)
- Dairy Products and Egg (4)
- Genomics (4)
- Chemical and Material (3)
- Cigarette > newspaper > liquor Stores (3)
- Oil and Gas Energy (3)
- E-healthcare (2)
- Education and Training (2)
- Energy & Environment (2)
- General Medicine and Specialty Medicine (2)
- In Vitro Diagnostic (2)
Top countries
Publication dates
All regions
data types
- All
- Company Data (506)
- Industry Data
- Country Data (160)
Schizophrenia Market and Forecasts, May 2013
You might be interested in: clinical trial, mental illness, mental health, more »
industry reports
country reports
Schizophrenia Sector in Netherlands
- Industry report
- April 2011
- 31 pages
... Define type i schizophrenia and type ii schizophrenia, as well as the types of symptoms usually experienced within each type of the disease. What was the first typical antipsychotic developed ...
- Industries: Pathology
- Countries: World, Netherlands
Pharmaceutical Industry Analysis in Australia, The United Kingdom and The United States
- Industry report
- February 2011
- 64 pages
... For psychosis (uhr) Trauma and psychosis. Psychosis Broad phenotype Ltp 3% Genetic and environmental contribution Highly variable outcomes Includes syndromes such as schizophrenia ...
- Industries: Pathology
- Countries: Australia, United Kingdom, United States
Mental Disorder Sector Trends in The United States
- Industry report
- June 2012
- 29 pages
... Reduced inhibitory activity excessive excitatory pruning raise rehab raise: recovery after initial schizophrenia episode " Individual resilience training " Family psycho- education ...
- Industries: Pathology
- Countries: United States
Mental Illness Market (mental illness, cardiovascular disease, autoimmune disease) in The United States
- Industry report
- September 2011
- 29 pages
... That is likely to have the greatest impact on decreasing mortality george tp et al. Nicotine and tobacco use in schizophrenia. In: meyer jm, nasrallah ha, eds. Medical illness and schizophrenia. American ...
- Industries: Pathology
- Countries: United States
Pharmaceutical in The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 45 pages
- by Corporation
... Bipolar in q4 16+) Partnered with otsuka aripiprazole depot vortioxetine opc-34712 expected launch 2015-16 Studies in treatment of schizophrenia and as adjunct in mdd Partnered ...
- Industries: Pathology
- Countries: United States
Pharmaceutical Industry Overview
- Industry report
- November 2011
- 38 pages
... Guidelines for schizophrenia update (2009) we now have good evidence that cbt and fi for psychosis works. Cbt evidence: 31 rcts reviewed, quality checks on methodology (n=3052). (22 New trials) small ...
- Industries: Pathology
Pharmaceutical in Europe and Israel : Innovation and Technology Trends
- Industry report
- August 2011
- 14 pages
- by Non Governmental Organization (NGO)
... Text borrowed from: institute of medicine, washington, dc, august 2011, cast as road map. schizophrenia database data from: astra zeneca, janssen, lilly, lundbeck, pfizer 64 industry sponsored ...
- Industries: Pharmaceutical
- Countries: Europe, Israel, United Kingdom
Pharmaceutical : Innovation and Technology Trends
- Industry report
- November 2012
- 39 pages
... Such as liver failure schizophrenia depression combined data analysis of 23,401 schizophrenia patients data from 45 randomized controlled studies of antidepressants on 11,000 patients De novo analysis pending ...
- Industries: Pathology
The Swiss Pharmaceutical Business
- Industry report
- June 2012
- 46 pages
... Antipsychotics are going off patent now Typical and atypical antipsychotics inhibit dopamine d2 receptor Address positive symptoms Significant unmet medical need in schizophrenia Negative symptoms ...
- Industries: Pathology
- Countries: Switzerland
Pharmaceutical Market in Switzerland
- Industry report
- June 2012
- 46 pages
... Antipsychotics are going off patent now Typical and atypical antipsychotics inhibit dopamine d2 receptor Address positive symptoms Significant unmet medical need in schizophrenia Negative symptoms ...
- Industries: Pathology
- Countries: Switzerland
» Purchase Premium Reports
About 4 200 reports for Schizophrenia
Reportlinker.com © Copyright 2013. All rights reserved.
